2-130598654-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032545.4(CFC1):c.235G>A(p.Ala79Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0 ( 0 hom., cov: 22)
Failed GnomAD Quality Control
Consequence
CFC1
NM_032545.4 missense
NM_032545.4 missense
Scores
1
18
Clinical Significance
Conservation
PhyloP100: 0.233
Genes affected
CFC1 (HGNC:18292): (cryptic, EGF-CFC family member 1) This gene encodes a member of the epidermal growth factor (EGF)- Cripto, Frl-1, and Cryptic (CFC) family, which are involved in signalling during embryonic development. Proteins in this family share a variant EGF-like motif, a conserved cysteine-rich domain, and a C-terminal hydrophobic region. The protein encoded by this gene is necessary for patterning the left-right embryonic axis. Mutations in this gene are associated with defects in organ development, including autosomal visceral heterotaxy and congenital heart disease. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jul 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0903863).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFC1 | NM_032545.4 | c.235G>A | p.Ala79Thr | missense_variant | 3/6 | ENST00000259216.6 | NP_115934.1 | |
CFC1 | NM_001270420.2 | c.235G>A | p.Ala79Thr | missense_variant | 3/5 | NP_001257349.1 | ||
CFC1 | NM_001270421.2 | c.235G>A | p.Ala79Thr | missense_variant | 3/4 | NP_001257350.1 | ||
CFC1 | XM_011511486.4 | c.235G>A | p.Ala79Thr | missense_variant | 3/4 | XP_011509788.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFC1 | ENST00000259216.6 | c.235G>A | p.Ala79Thr | missense_variant | 3/6 | 1 | NM_032545.4 | ENSP00000259216 | P1 | |
CFC1 | ENST00000615342.4 | c.235G>A | p.Ala79Thr | missense_variant | 3/5 | 5 | ENSP00000480526 | |||
CFC1 | ENST00000621673.4 | c.235G>A | p.Ala79Thr | missense_variant | 3/4 | 2 | ENSP00000480843 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 152222Hom.: 0 Cov.: 22 FAILED QC
GnomAD3 genomes
AF:
AC:
0
AN:
152222
Hom.:
Cov.:
22
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 152222Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 74364
GnomAD4 genome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
AC:
0
AN:
152222
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
74364
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 02, 2024 | The c.235G>A (p.A79T) alteration is located in exon 3 (coding exon 3) of the CFC1 gene. This alteration results from a G to A substitution at nucleotide position 235, causing the alanine (A) at amino acid position 79 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;L
MutationTaster
Benign
N
PrimateAI
Benign
T
PROVEAN
Benign
.;.;N
REVEL
Benign
Sift
Benign
.;.;T
Sift4G
Pathogenic
D;D;T
Polyphen
0.064
.;.;B
Vest4
MutPred
Gain of phosphorylation at A79 (P = 0.0409);Gain of phosphorylation at A79 (P = 0.0409);Gain of phosphorylation at A79 (P = 0.0409);
MVP
MPC
1.3
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at